Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04019379 · ClinicalTrials.gov registry record · NA

Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
3
Enrollment target

NCT04019379: Completed NA study, sponsored by University of Minnesota.

NCT04019379 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04019379, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

This pilot study aims to develop a method for simultaneous whole-body calcium and phosphorus balance and full kinetic modeling of both ions in patients with chronic kidney disease.

Primary Outcome

Determined by kinetic modeling of serum and urine Ca-44 isotope after oral and IV isotope administrations

Interventions

  • OTHER High Phosphorus Diet
  • OTHER Low Phosphorus Diet

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2020-08-31
Est. Completion 2023-01-30
Phase NA
University of Minnesota

966 total trials

What the finished NCT04019379 record still lists

NCT04019379 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which High Phosphorus Diet is the first listed.

NCT04019379 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04019379 about?

NCT04019379 is a clinical study titled "Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease". This pilot study aims to develop a method for simultaneous whole-body calcium and phosphorus balance and full kinetic modeling of both ions in patients with chronic kidney disease.

What is the current status of trial NCT04019379?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2020-08-31. Estimated completion is 2023-01-30.

What interventions are being tested in trial NCT04019379?

The interventions under investigation include: High Phosphorus Diet (OTHER), Low Phosphorus Diet (OTHER).

Who is sponsoring clinical trial NCT04019379?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04019379's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04019379, the US trial registry maintained by the National Library of Medicine. NCT04019379 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.